Influence of preload, afterload, and contractility on myocardial ultrasonic tissue characterization with integrated backscatter.
Influence of hemodynamic changes in preload, afterload and contractility on myocardial integrated backscatter (IB) was studied in 26 adult mongrel dogs by measuring myocardial IB calibrated with the backscatter from the blood during volume infusion (preload alteration), during aortic constriction (afterload alteration), and during dobutamine or propranolol infusion (contractility alteration). Changes in preload, afterload or contractility did not significantly affect the calibrated myocardial IB either in the septum or in the posterior wall. Changes in preload and afterload did not affect the magnitude of cyclic variation in IB. However, dobutamine produced a significant increase in the magnitude of cyclic variation in IB and propranolol significantly decreased the magnitude of cyclic variation in IB. These data indicated that the calibrated myocardial IB is independent of preload, afterload and contractility, and that the magnitude of cyclic variation in IB is influenced by contractility. We may estimate static (related to histological changes such as fibrosis, edema, necrosis, and so on) and dynamic (related to myocardial contraction such as sarcomere length, muscle fiber orientation, and so on) properties of the myocardium more precisely using myocardial IB calibrated with the backscatter from the blood in addition to the magnitude of cyclic variation in IB.
Naito
J
J
First Department of Medicine, Osaka University School of Medicine, Suita, Japan.
Masuyama
T
T
Mano
T
T
Yamamoto
K
K
Doi
Y
Y
Kondo
H
H
Nagano
R
R
Inoue
M
M
Hori
M
M
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000704:Analysis of Variance; D000818:Animals; D003326:Coronary Circulation; D004280:Dobutamine / Q000494:pharmacology; D004285:Dogs; D004452:Echocardiography / Q000379:methods*; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006438:Hemodilution; D006439:Hemodynamics / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects / Q000502:physiology*; D011433:Propranolol / Q000494:pharmacology; D016277:Ventricular Function, Left / Q000502:physiology
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D004280:Dobutamine; D011433:Propranolol